Ключевые слова:
дифференцированный рак щитовидной железы, TI-RADS, система Bethesda, тиреоглобулин, антитела к тиреоглобулину, раковый эмбриональный антиген, стратифи- кация риска.Библиографические ссылки
1. Cibas ES, Ali SZ. The Bethesda System for Reporting Thy- roid Cytopathology. Thyroid.2017;27(11):1341-6.
2. Filetti S, Durante C, Hartl D et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and fol- low-up. Ann Oncol.2019;30(12):1856-83.
3. Haugen BR, Alexander EK, Bible KC et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thy- roid 2016;26(1):1-133.
4. Kim M, Kim WG, Oh HS et al. Prognostic value of se- rum thyroglobulin and anti-thyroglobulin antibody lev- els in differentiated thyroid cancer. J. Clin Endocrinol Me-
tab.2020;105(2):e370-e9.
5. Liu J, Liu R, Shen X et al. Prognostic significance of car- cinoembryonic antigen in thyroid carcinoma. Front Endocri- nol.2021;12:645-52.
6. Rosario PW, Mourão GF, Calsolari MR. Preoperative se- rum thyroglobulin as a prognostic marker in differentiated thyroid cancer. Clin Endocrinol.2019;91(5):723-9.
7. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2024. CA: A Cancer J Clin.2024;74(1):17-48.
8. Tessler FN, Middleton WD, Grant EG et al. ACR Thy- roid Imaging, Reporting and Data System (TI-RADS): White paper of the ACR TI-RADS Committee. J Amer Coll Radi- ol.2017;14(5):587-95.
9. Trimboli P, Castellana M, Virili C et al. Performance of ultrasound risk stratification systems in thyroid nodules: A systematic review and meta-analysis. Europ J Endocri- nol.2020;183(4):401-12.
Trimboli P, Piccardo A, Signore A. The role of thyroglob- ulin in preoperative risk stratification of differentiated thyroid cancer. Endocrine. 2020;68(1):1-9.
